QVIDTVM Management LLC
In its 13F for Q2 2026 (holdings as of June 30, 2026, filed August 13, 2026), QVIDTVM Management LLC reported 14 stock positions worth $76.6 million. Its top holding was Bio-Rad Laboratories-A (BIO) at 25.4% of the portfolio, followed by Nebius (NBIS, 17.5%) and Amrize (AMRZ, 17.2%). Compared with Q1 2026, it opened 1 new position, sold out of 1, added to 3 and reduced 10. The biggest buy was Oracle (ORCL, shares +46%) and the biggest sale Solventum (SOLV, shares −66%).
- Most Recent 13F
- Q2 2026
- Location
- THE WOODLANDS, TX
- CIK
- 0001912226
- Portfolio Value
- $76.6M (Q2 2026)
- SEC Filing
- 0001912226-26-000003 ↗ filed Aug 13, 2026
Holdings Value
Holdings 14 stocks · $76.6M
| BIO Bio-Rad Laboratories-A | 25.39% | 66,243 | $19.4M | Reduce -20.9% |
| NBIS Nebius Group NV | 17.54% | 48,657 | $13.4M | Reduce -19.8% |
| AMRZ Amrize Ltd. | 17.21% | 247,391 | $13.2M | Add +13.8% |
| ORCL Oracle Corp. | 10.90% | 56,970 | $8.3M | Add +46.4% |
| SOLV Solventum Corp. | 8.97% | 89,033 | $6.9M | Reduce -66.5% |
| ZGN Ermenegildo Zegna NV | 7.75% | 455,804 | $5.9M | Reduce -13.3% |
| ARE Alexandria Real Estate Equit | 5.69% | 82,470 | $4.4M | Add +106.2% |
| BRC INC-A | 4.28% | 2,953,138 | $3.3M | Reduce -13.2% |
| OCTV Octave Intelligence Class B | 1.22% | 57,466 | $937K | New |
| WAB Wabtec Corp. | 0.26% | 750 | $202K | Reduce -72.9% |
| XRAY Dentsply Sirona Inc. | 0.26% | 18,929 | $201K | Reduce -95.1% |
| PM Philip Morris International | 0.24% | 1,026 | $186K | Reduce -4.9% |
| LAB Standard Biotools Inc. | 0.24% | 222,000 | $183K | Reduce -3.2% |
| HRB H&R Block Inc. filed as BLOCK H & R INC | 0.04% | 844 | $32K | Reduce -96.4% |
Portfolio Sells Q1 2026 → Q2 2026
| SOLV Solventum Corp. | Reduce -66.5% | 8.97% | −12.35 |
| XRAY Dentsply Sirona Inc. | Reduce -95.1% | 0.26% | −5.23 |
| BIO Bio-Rad Laboratories-A | Reduce -20.9% | 25.39% | −3.29 |
| HRB H&R Block Inc. | Reduce -96.4% | 0.04% | −0.87 |
| WAB Wabtec Corp. | Reduce -72.9% | 0.26% | −0.59 |
| RTO Rentokil Initial PLC-SP ADR | Sold out | 0.00% | −0.27 |
| LAB Standard Biotools Inc. | Reduce -3.2% | 0.24% | −0.02 |
| PM Philip Morris International | Reduce -4.9% | 0.24% | +0.02 |
| ZGN Ermenegildo Zegna NV | Reduce -13.3% | 7.75% | +1.01 |
| BRC INC-A | Reduce -13.2% | 4.28% | +1.04 |
| NBIS Nebius Group NV | Reduce -19.8% | 17.54% | +9.80 |
Portfolio Buys Q1 2026 → Q2 2026
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 14 | $76.6M | BIO, NBIS, AMRZ, ORCL, SOLV |
| Q1 2026 | 14 | $81.4M | BIO, SOLV, AMRZ, NBIS, ORCL |
| Q4 2025 | 13 | $88.4M | BIO, SOLV, AMRZ, XRAY, ZGN |
| Q3 2025 | 8 | $92.9M | SOLV, BIO, COTY, XRAY, BRC INC-A |
| Q2 2025 | 8 | $99.8M | SOLV, BIO, COTY, XRAY, RTO |
| Q1 2025 | 8 | $113.1M | SOLV, BIO, RTO, COTY, XRAY |
| Q4 2024 | 8 | $124.2M | BIO, SOLV, RTO, BRC INC-A, XRAY |
| Q3 2024 | 8 | $142.9M | BIO, SOLV, WAB, RTO, XRAY |
| Q2 2024 | 7 | $125.0M | BIO, RTO, SOLV, WAB, BRC INC-A |
| Q1 2024 | 10 | $124.2M | BIO, RTO, WAB, BRC INC-A, XRAY |